Will more states press pause on Medicaid disenrollments?
Michigan is taking up the government’s offer of a one-month delay and 10 other states are considering it.
By Rachel Roubein and McKenzie BeardBig Pharma has a new strategy to fight drug negotiation
In a legal blitz, four lawsuits were filed this month in four different court venues.
By Rachel Roubein and McKenzie BeardThe conservative doctors upending trans rights
The American College of Pediatricians has promoted views on abortion and transgender care that have been rejected by the medical establishment. But their views are still shaping conservative laws restricting abortion and trans rights across the country.
By Maggie Penman, Tracy Jan, Gabe O'Connor, Sean Carter and Reena FloresWalensky says reforming CDC will take ‘longer than any single director’s tenure’
An exit interview with outgoing CDC Director Rochelle Walensky.
By Lena H. Sun, McKenzie Beard and Rachel RoubeinHow troubles at a factory in India led to a U.S. cancer-drug shortage
Intas Pharmaceuticals in India made a widely used cancer drug in the U.S. An inspection exposed problems — and the fragility of the U.S. generic-drug supply.
By Daniel GilbertPenn Medicine quits cooperating with U.S. News hospitals ranking
The University of Pennsylvania Health System, a top-ranked system, will walk away from the influential lists.
By Susan SvrlugaPfizer picks its pill in race for Ozempic-like weight-loss drug
Pfizer will move ahead with a pill version of a weight-loss drug as competition heats up for an oral medication that can rival Ozempic and other GLP-1 drugs.
By Daniel GilbertAbortion politics paves the road to 2024
What happens next year could further upend the nation’s new abortion landscape.
By Rachel Roubein and McKenzie BeardThe state of abortion in post-Roe America
We look at the nation’s abortion landscape a year after the Supreme Court overturned Roe v. Wade.
By Rachel Roubein and McKenzie BeardHow blue states are responding to the post-Roe world
They've passed bills solidifying abortion rights, expanding medication abortion access and preemptively shielding providers.
By Rachel Roubein and McKenzie BeardHow Democrats will highlight abortion restrictions this week
Saturday marks one year since the Supreme Court decision overturning Roe v. Wade.
By Rachel Roubein and McKenzie BeardLove, leather and fighting the next mpox outbreak
Come for the leather kink, stay for the lifesaving health care outreach. Today on “Post Reports,” health reporter Fenit Nirappil embeds on the front lines of preventing the next mpox outbreak at International Mr. Leather in Chicago.
By Maggie Penman, Elana Gordon, Sean Carter and Monica CampbellAnother covid booster is coming. But how many will get it?
Only a sliver of Americans got the last shot, which doesn't bode well for the next variant-targeting vaccine.
By Rachel Roubein and McKenzie BeardNearly 6 in 10 Americans report problems with their health coverage
Problems persist despite more than a decade of efforts to improve insurance for consumers.
By Rachel Roubein and McKenzie BeardCDC director weathers lawmakers’ covid criticism one final time
Rochelle Walensky got one last chance to defend her legacy to skeptical House Republicans yesterday.
By McKenzie Beard and Rachel RoubeinThe clashing approaches to classifying fentanyl
Today, Sen. Cory Booker plans to reintroduce legislation extending Schedule 1 classification of fentanyl-related substances temporarily.
By Rachel Roubein and McKenzie BeardHow Biden built his own 'Harvard Faculty Club'
Time and time again, the president has picked Harvard-trained physicians for top health roles.
By Dan Diamond and McKenzie BeardFDA advisers to discuss full approval of Alzheimer's drug
The agency appears open to traditional approval of the drug Leqembi.
By Rachel Roubein and McKenzie BeardWhere the latest GOP candidates stand on abortion
We checked in with Mike Pence, Chris Christie and Doug Burgum.
By Rachel Roubein and McKenzie BeardHow Merck intends to fight Medicare drug price negotiation
Merck is the first to sue the federal government over the law passed in August.
By Rachel Roubein and McKenzie Beard